Pharmacokinetic profiles of doxorubicin in combination with taxanes

被引：20

作者：

Holmes, FA

Rowinsky, EK

机构：

[1] US Oncol Texas Oncol PA, San Antonio, TX USA

[2] Canc Therapy & Res Ctr, Inst Drug Dev, San Antonio, TX 78229 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1053/sonc.2001.26435

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：8 / 14

页数：7

共 25 条

[1]

BELLOT R, 1998, P AN M AM SOC CLIN, V17, pA221

[2] PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION [J].

BERG, SL ;

COWAN, KH ;

BALIS, FM ;

FISHERMAN, JS ;

DENICOFF, AM ;

HILLIG, M ;

POPLACK, DG ;

OSHAUGHNESSY, JA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (02) :143-145

[3] USE OF THE ISOLATED PERFUSED KIDNEY MODEL TO ASSESS THE ACUTE PHARMACOLOGICAL EFFECTS OF CYCLOSPORINE AND ITS VEHICLE, CREMOPHOR EL [J].

BESARAB, A ;

JARRELL, BE ;

HIRSCH, S ;

CARABASI, RA ;

CRESSMAN, MD ;

GREEN, P .

TRANSPLANTATION, 1987, 44 (02) :195-201

[4]

DIERAS V, 1998, BREAST CANC RES TREA, V50, P262

[5]

DUDEJA PR, 1995, ARCH BIOCHEM BIOPHYS, V319, P308

[6] The taxoids - Comparative clinical pharmacology and therapeutic potential [J].

Eisenhauer, EA ;

Vermorken, JB .

DRUGS, 1998, 55 (01) :5-30

[7]

FRICHE E, 1990, CANCER COMMUN, V2, P297

[8] HYPERSENSITIVITY REACTIONS FROM TAXOL AND ETOPOSIDE [J].

FRIEDLAND, D ;

GORMAN, G ;

TREAT, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (24) :2036-2036

[9]

Gehl J, 1996, ANN ONCOL, V7, P687

[10]

Gianni L, 1998, ONCOLOGY-NY, V12, P13

← 1 2 3 →